Replacement Therapy and its Impact on Quality of Life in Patients with end-stage Kidney Disease

Abstract

Objective: to assess the quality of life (QoL) score according to the type of renal replacement therapy (rrt) in patients with end-stage renal disease (esrd). Methods: cross-sectional, analytical study. Patients with esrd, on peritoneal dialysis (pd) or hemodialysis (hd), older than 18 years, without disease exacerbation, assigned to the Regional General Hospital No. 1 of Mexico City, were included. The study was carried out from December 2018 to March 2019. QoL was measured with the eq-5D index and the visual analogue scale to obtain a health self-assessment index; clinical and sociodemographic variables were obtained from the medical record and through interrogation. Results: a total of 406 participants, 203 patients on hemodialysis and 203 on pd, were included. A mean eq-5D index score of 0.46 ± 0.18 was found for pd versus 0.29 ± 0.22 for hd (p < 0.001). The self-assessment index showed no difference between both groups. The quality of life indicators that were most affected in patients treated with hd were pain and anxiety or depression. Conclusion: in patients with end-stage renal disease, hd is associated with lower quality of life.